| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 86 | 2022 | 1034 | 13.360 |
Why?
|
| Tobacco Use Disorder | 28 | 2022 | 432 | 7.140 |
Why?
|
| Smoking | 47 | 2021 | 1452 | 5.380 |
Why?
|
| Electronic Nicotine Delivery Systems | 11 | 2022 | 180 | 3.830 |
Why?
|
| Hotlines | 9 | 2017 | 51 | 2.880 |
Why?
|
| Nicotine | 16 | 2022 | 350 | 2.340 |
Why?
|
| Smoking Prevention | 11 | 2020 | 259 | 2.290 |
Why?
|
| Vaping | 4 | 2022 | 124 | 2.280 |
Why?
|
| Neoplasms | 15 | 2022 | 1667 | 2.060 |
Why?
|
| Tobacco Products | 8 | 2022 | 234 | 2.050 |
Why?
|
| Counseling | 9 | 2017 | 280 | 2.020 |
Why?
|
| Alcoholism | 9 | 2022 | 1109 | 1.810 |
Why?
|
| Text Messaging | 6 | 2018 | 47 | 1.570 |
Why?
|
| Lung Neoplasms | 15 | 2022 | 1173 | 1.560 |
Why?
|
| Motivation | 14 | 2021 | 561 | 1.480 |
Why?
|
| Cigarette Smoking | 2 | 2022 | 104 | 1.410 |
Why?
|
| Bupropion | 10 | 2022 | 63 | 1.380 |
Why?
|
| Alcohol Drinking | 11 | 2018 | 805 | 1.290 |
Why?
|
| Humans | 113 | 2022 | 68618 | 1.240 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 711 | 1.220 |
Why?
|
| Adult | 56 | 2022 | 21403 | 1.200 |
Why?
|
| Naltrexone | 11 | 2015 | 195 | 1.180 |
Why?
|
| Female | 71 | 2022 | 38074 | 1.050 |
Why?
|
| Male | 69 | 2022 | 37321 | 1.040 |
Why?
|
| Weight Gain | 4 | 2010 | 135 | 1.020 |
Why?
|
| Middle Aged | 46 | 2022 | 21147 | 1.010 |
Why?
|
| Early Detection of Cancer | 11 | 2022 | 454 | 1.010 |
Why?
|
| Surveys and Questionnaires | 14 | 2019 | 2800 | 0.930 |
Why?
|
| Inpatients | 2 | 2021 | 208 | 0.820 |
Why?
|
| Mental Recall | 2 | 2016 | 72 | 0.770 |
Why?
|
| Self Report | 7 | 2021 | 371 | 0.770 |
Why?
|
| Persuasive Communication | 3 | 2013 | 7 | 0.760 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 148 | 0.760 |
Why?
|
| Substance Withdrawal Syndrome | 5 | 2022 | 435 | 0.750 |
Why?
|
| Patient Education as Topic | 5 | 2019 | 425 | 0.750 |
Why?
|
| Health Behavior | 3 | 2021 | 458 | 0.730 |
Why?
|
| Attitude | 1 | 2021 | 121 | 0.720 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2022 | 931 | 0.720 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 91 | 0.710 |
Why?
|
| Affect | 4 | 2013 | 218 | 0.700 |
Why?
|
| Secondary Prevention | 3 | 2018 | 291 | 0.690 |
Why?
|
| Treatment Outcome | 19 | 2022 | 7029 | 0.680 |
Why?
|
| Tobacco Smoking | 1 | 2019 | 41 | 0.670 |
Why?
|
| Narcotic Antagonists | 6 | 2014 | 184 | 0.640 |
Why?
|
| Telephone | 3 | 2010 | 160 | 0.630 |
Why?
|
| Self Disclosure | 3 | 2008 | 55 | 0.630 |
Why?
|
| Hospitals | 1 | 2020 | 265 | 0.620 |
Why?
|
| Time Factors | 9 | 2019 | 4655 | 0.610 |
Why?
|
| Electronic Health Records | 3 | 2019 | 374 | 0.610 |
Why?
|
| Mass Screening | 5 | 2021 | 843 | 0.600 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2008 | 152 | 0.600 |
Why?
|
| Patient Compliance | 3 | 2010 | 402 | 0.590 |
Why?
|
| Hospitalization | 3 | 2019 | 978 | 0.590 |
Why?
|
| Tobacco Use Cessation | 3 | 2014 | 44 | 0.580 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 191 | 0.570 |
Why?
|
| Motivational Interviewing | 5 | 2017 | 40 | 0.570 |
Why?
|
| Attitude to Health | 4 | 2013 | 403 | 0.550 |
Why?
|
| Behavioral Medicine | 1 | 2016 | 23 | 0.550 |
Why?
|
| United States | 19 | 2022 | 7367 | 0.550 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 88 | 0.540 |
Why?
|
| Judgment | 1 | 2016 | 40 | 0.530 |
Why?
|
| Risk Assessment | 5 | 2018 | 2007 | 0.520 |
Why?
|
| Comprehension | 1 | 2016 | 71 | 0.520 |
Why?
|
| Cell Phone | 1 | 2016 | 44 | 0.520 |
Why?
|
| Decision Making | 2 | 2016 | 410 | 0.510 |
Why?
|
| Directive Counseling | 3 | 2016 | 23 | 0.510 |
Why?
|
| Pilot Projects | 9 | 2022 | 1342 | 0.500 |
Why?
|
| Tobacco Use | 6 | 2022 | 98 | 0.480 |
Why?
|
| Liver Transplantation | 1 | 2018 | 400 | 0.480 |
Why?
|
| Young Adult | 19 | 2022 | 5717 | 0.470 |
Why?
|
| Tobacco | 7 | 2022 | 161 | 0.460 |
Why?
|
| Referral and Consultation | 4 | 2017 | 383 | 0.460 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 772 | 0.460 |
Why?
|
| Behavior, Addictive | 2 | 2008 | 317 | 0.440 |
Why?
|
| Medication Adherence | 4 | 2011 | 335 | 0.430 |
Why?
|
| Repression, Psychology | 2 | 2010 | 3 | 0.420 |
Why?
|
| Medical Oncology | 5 | 2022 | 110 | 0.420 |
Why?
|
| Antidepressive Agents, Second-Generation | 4 | 2013 | 54 | 0.410 |
Why?
|
| Health Promotion | 1 | 2016 | 407 | 0.410 |
Why?
|
| New York | 4 | 2014 | 223 | 0.410 |
Why?
|
| Smokers | 5 | 2021 | 200 | 0.400 |
Why?
|
| Behavior Therapy | 2 | 2021 | 297 | 0.390 |
Why?
|
| Adolescent | 15 | 2022 | 8912 | 0.380 |
Why?
|
| Alcohol-Related Disorders | 4 | 2015 | 95 | 0.370 |
Why?
|
| Bulimia | 1 | 2010 | 72 | 0.360 |
Why?
|
| Poverty | 3 | 2016 | 219 | 0.360 |
Why?
|
| Recurrence | 5 | 2018 | 948 | 0.350 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2021 | 468 | 0.350 |
Why?
|
| Self Concept | 1 | 2010 | 132 | 0.350 |
Why?
|
| Transdermal Patch | 3 | 2019 | 21 | 0.350 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 3259 | 0.350 |
Why?
|
| Feasibility Studies | 4 | 2022 | 652 | 0.320 |
Why?
|
| Feeding Behavior | 1 | 2010 | 224 | 0.320 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 2 | 2005 | 19 | 0.310 |
Why?
|
| Aged | 16 | 2022 | 14862 | 0.300 |
Why?
|
| Factor Analysis, Statistical | 6 | 2012 | 201 | 0.300 |
Why?
|
| Appetite | 1 | 2007 | 16 | 0.290 |
Why?
|
| Advisory Committees | 3 | 2016 | 73 | 0.290 |
Why?
|
| Varenicline | 4 | 2022 | 98 | 0.290 |
Why?
|
| Telemedicine | 3 | 2022 | 700 | 0.290 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2019 | 504 | 0.280 |
Why?
|
| Cognition | 1 | 2010 | 513 | 0.270 |
Why?
|
| Glucuronates | 2 | 2018 | 19 | 0.270 |
Why?
|
| Demography | 3 | 2013 | 279 | 0.270 |
Why?
|
| Double-Blind Method | 8 | 2015 | 1738 | 0.270 |
Why?
|
| Ethanol | 5 | 2015 | 893 | 0.270 |
Why?
|
| Clinical Trials as Topic | 4 | 2019 | 848 | 0.270 |
Why?
|
| Health Education | 2 | 2010 | 279 | 0.260 |
Why?
|
| Marketing | 1 | 2005 | 26 | 0.250 |
Why?
|
| Risk Factors | 9 | 2019 | 5731 | 0.250 |
Why?
|
| Biomedical Research | 3 | 2020 | 310 | 0.250 |
Why?
|
| Communication | 1 | 2007 | 329 | 0.250 |
Why?
|
| Risk Reduction Behavior | 2 | 2019 | 174 | 0.250 |
Why?
|
| Tobacco Industry | 1 | 2005 | 55 | 0.250 |
Why?
|
| Depression | 2 | 2010 | 943 | 0.250 |
Why?
|
| Policy | 3 | 2022 | 58 | 0.240 |
Why?
|
| Health Policy | 3 | 2015 | 221 | 0.240 |
Why?
|
| Information Services | 1 | 2003 | 22 | 0.230 |
Why?
|
| Lung | 4 | 2022 | 849 | 0.230 |
Why?
|
| Survival Rate | 4 | 2020 | 1056 | 0.230 |
Why?
|
| Sex Factors | 5 | 2016 | 1266 | 0.220 |
Why?
|
| Program Evaluation | 4 | 2018 | 502 | 0.220 |
Why?
|
| Chronic Disease | 3 | 2019 | 1330 | 0.220 |
Why?
|
| Tablets | 1 | 2022 | 19 | 0.220 |
Why?
|
| Administration, Cutaneous | 4 | 2014 | 56 | 0.220 |
Why?
|
| Information Dissemination | 1 | 2003 | 113 | 0.210 |
Why?
|
| Sexual Partners | 2 | 2013 | 106 | 0.200 |
Why?
|
| Impulsive Behavior | 3 | 2014 | 85 | 0.200 |
Why?
|
| Evidence-Based Medicine | 4 | 2016 | 438 | 0.200 |
Why?
|
| Alcoholic Intoxication | 2 | 2014 | 61 | 0.200 |
Why?
|
| Risk-Taking | 2 | 2014 | 210 | 0.200 |
Why?
|
| Government Regulation | 3 | 2016 | 46 | 0.200 |
Why?
|
| Reproducibility of Results | 5 | 2008 | 2077 | 0.200 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2021 | 106 | 0.200 |
Why?
|
| Anxiety | 3 | 2015 | 422 | 0.190 |
Why?
|
| Preoperative Period | 1 | 2021 | 50 | 0.190 |
Why?
|
| Internet | 1 | 2003 | 390 | 0.180 |
Why?
|
| Patient Participation | 2 | 2020 | 146 | 0.180 |
Why?
|
| Prognosis | 3 | 2018 | 2093 | 0.180 |
Why?
|
| Combined Modality Therapy | 4 | 2015 | 951 | 0.180 |
Why?
|
| Aftercare | 1 | 2021 | 114 | 0.180 |
Why?
|
| Connecticut | 2 | 2019 | 13 | 0.180 |
Why?
|
| Product Labeling | 1 | 2020 | 43 | 0.180 |
Why?
|
| Prospective Studies | 4 | 2019 | 3705 | 0.170 |
Why?
|
| Exercise | 2 | 2018 | 658 | 0.170 |
Why?
|
| Cholinergic Agents | 1 | 2019 | 12 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 504 | 0.170 |
Why?
|
| Aneurysm | 1 | 2019 | 53 | 0.170 |
Why?
|
| Patient Care Planning | 1 | 2019 | 108 | 0.170 |
Why?
|
| Qualitative Research | 2 | 2017 | 369 | 0.170 |
Why?
|
| Comorbidity | 4 | 2016 | 1426 | 0.160 |
Why?
|
| Delayed-Action Preparations | 3 | 2008 | 120 | 0.160 |
Why?
|
| Guidelines as Topic | 2 | 2016 | 123 | 0.160 |
Why?
|
| Peripheral Arterial Disease | 1 | 2019 | 83 | 0.150 |
Why?
|
| Nicotine Chewing Gum | 1 | 2017 | 1 | 0.150 |
Why?
|
| Psychometrics | 4 | 2015 | 514 | 0.150 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2018 | 27 | 0.150 |
Why?
|
| Harm Reduction | 1 | 2017 | 21 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 109 | 0.150 |
Why?
|
| Social Support | 2 | 2019 | 423 | 0.150 |
Why?
|
| Models, Theoretical | 1 | 2020 | 384 | 0.150 |
Why?
|
| Research | 2 | 2016 | 214 | 0.150 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 99 | 0.150 |
Why?
|
| Public Health | 2 | 2016 | 201 | 0.150 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 93 | 0.150 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 106 | 0.140 |
Why?
|
| Drug Therapy, Combination | 2 | 2010 | 649 | 0.140 |
Why?
|
| Binge Drinking | 2 | 2014 | 50 | 0.140 |
Why?
|
| Self-Assessment | 2 | 2008 | 69 | 0.140 |
Why?
|
| New England | 1 | 2016 | 16 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 2324 | 0.140 |
Why?
|
| Nicotinic Agonists | 2 | 2022 | 111 | 0.140 |
Why?
|
| Exercise Therapy | 1 | 2018 | 183 | 0.140 |
Why?
|
| Language Tests | 1 | 2016 | 36 | 0.130 |
Why?
|
| Biomarkers | 2 | 2019 | 1593 | 0.130 |
Why?
|
| Software | 1 | 2019 | 418 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2019 | 622 | 0.130 |
Why?
|
| Withholding Treatment | 1 | 2016 | 35 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 782 | 0.130 |
Why?
|
| User-Computer Interface | 1 | 2017 | 230 | 0.130 |
Why?
|
| American Medical Association | 1 | 2015 | 21 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2014 | 1040 | 0.120 |
Why?
|
| Drinking Behavior | 1 | 2014 | 20 | 0.120 |
Why?
|
| HIV Infections | 1 | 2022 | 791 | 0.120 |
Why?
|
| South Carolina | 2 | 2018 | 2752 | 0.120 |
Why?
|
| Sulfuric Acid Esters | 1 | 2014 | 7 | 0.120 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2014 | 14 | 0.120 |
Why?
|
| Substance Abuse Detection | 1 | 2014 | 66 | 0.120 |
Why?
|
| Menthol | 1 | 2013 | 11 | 0.110 |
Why?
|
| Medicare | 3 | 2022 | 319 | 0.110 |
Why?
|
| Physicians | 1 | 2017 | 324 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2009 | 767 | 0.110 |
Why?
|
| Menstrual Cycle | 2 | 2010 | 64 | 0.110 |
Why?
|
| Craving | 1 | 2015 | 200 | 0.110 |
Why?
|
| Physician's Role | 1 | 2014 | 116 | 0.110 |
Why?
|
| North Carolina | 1 | 2013 | 224 | 0.110 |
Why?
|
| Data Collection | 3 | 2013 | 420 | 0.110 |
Why?
|
| Temperance | 1 | 2012 | 41 | 0.110 |
Why?
|
| National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2012 | 2 | 0.110 |
Why?
|
| Preventive Medicine | 1 | 2013 | 48 | 0.110 |
Why?
|
| Intention | 2 | 2010 | 80 | 0.100 |
Why?
|
| Drug Administration Schedule | 2 | 2011 | 567 | 0.100 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2012 | 127 | 0.100 |
Why?
|
| Social Behavior | 2 | 2009 | 164 | 0.100 |
Why?
|
| Follicular Phase | 1 | 2010 | 15 | 0.090 |
Why?
|
| Luteal Phase | 1 | 2010 | 25 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2011 | 78 | 0.090 |
Why?
|
| Internal-External Control | 1 | 2010 | 60 | 0.090 |
Why?
|
| Marijuana Smoking | 1 | 2011 | 108 | 0.090 |
Why?
|
| Benzazepines | 1 | 2011 | 104 | 0.090 |
Why?
|
| Students | 2 | 2009 | 233 | 0.090 |
Why?
|
| Sleep Wake Disorders | 1 | 2011 | 94 | 0.090 |
Why?
|
| Incidence | 3 | 2020 | 1603 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 442 | 0.090 |
Why?
|
| Motor Activity | 1 | 2013 | 621 | 0.080 |
Why?
|
| Educational Status | 1 | 2010 | 273 | 0.080 |
Why?
|
| Observer Variation | 1 | 2009 | 330 | 0.080 |
Why?
|
| Irritable Mood | 1 | 2008 | 15 | 0.080 |
Why?
|
| Cotinine | 1 | 2008 | 40 | 0.080 |
Why?
|
| Logistic Models | 1 | 2012 | 1420 | 0.080 |
Why?
|
| Suggestion | 1 | 2008 | 2 | 0.080 |
Why?
|
| Carbon Monoxide | 1 | 2008 | 58 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2010 | 295 | 0.080 |
Why?
|
| Minnesota | 1 | 2007 | 27 | 0.070 |
Why?
|
| Dietary Sucrose | 1 | 2007 | 18 | 0.070 |
Why?
|
| Food Preferences | 1 | 2007 | 46 | 0.070 |
Why?
|
| Taste | 1 | 2007 | 49 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2007 | 103 | 0.070 |
Why?
|
| Placebos | 1 | 2007 | 195 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2010 | 867 | 0.070 |
Why?
|
| Regression Analysis | 3 | 2014 | 737 | 0.070 |
Why?
|
| Syndrome | 1 | 2007 | 255 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 1753 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2007 | 180 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 1851 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 218 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2007 | 285 | 0.070 |
Why?
|
| Feminism | 1 | 2005 | 1 | 0.060 |
Why?
|
| Central Nervous System Depressants | 1 | 2006 | 182 | 0.060 |
Why?
|
| Commerce | 1 | 2005 | 80 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2010 | 824 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2003 | 49 | 0.060 |
Why?
|
| Computer-Assisted Instruction | 1 | 2003 | 74 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2016 | 2279 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 4848 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1553 | 0.050 |
Why?
|
| Alcohol Deterrents | 2 | 2014 | 86 | 0.050 |
Why?
|
| Perception | 2 | 2013 | 189 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2015 | 403 | 0.050 |
Why?
|
| Thinking | 1 | 2001 | 30 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1745 | 0.050 |
Why?
|
| Confidentiality | 1 | 2020 | 62 | 0.040 |
Why?
|
| Body Weight | 2 | 2013 | 554 | 0.040 |
Why?
|
| Age Factors | 2 | 2016 | 1864 | 0.040 |
Why?
|
| Adaptation, Psychological | 2 | 2015 | 447 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 45 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 82 | 0.040 |
Why?
|
| Research Report | 1 | 2019 | 35 | 0.040 |
Why?
|
| Cell Phone Use | 1 | 2018 | 4 | 0.040 |
Why?
|
| Reinforcement, Social | 1 | 2018 | 7 | 0.040 |
Why?
|
| Accelerometry | 1 | 2018 | 61 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 168 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2018 | 111 | 0.040 |
Why?
|
| Pamphlets | 1 | 2016 | 27 | 0.030 |
Why?
|
| Program Development | 1 | 2018 | 240 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 445 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 800 | 0.030 |
Why?
|
| Walking | 1 | 2018 | 241 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2016 | 242 | 0.030 |
Why?
|
| Social Facilitation | 1 | 2015 | 5 | 0.030 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 366 | 0.030 |
Why?
|
| Family Health | 1 | 2015 | 83 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1038 | 0.030 |
Why?
|
| Nonprescription Drugs | 1 | 2014 | 28 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2014 | 85 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 131 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 880 | 0.030 |
Why?
|
| Medicaid | 1 | 2016 | 302 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1046 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 55 | 0.030 |
Why?
|
| Culture | 1 | 2012 | 75 | 0.030 |
Why?
|
| Risk | 1 | 2012 | 563 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2011 | 253 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2010 | 392 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1465 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 378 | 0.020 |
Why?
|
| Life Change Events | 1 | 2009 | 223 | 0.020 |
Why?
|
| Breath Tests | 1 | 2008 | 23 | 0.020 |
Why?
|
| Universities | 1 | 2009 | 191 | 0.020 |
Why?
|
| Social Environment | 1 | 2009 | 182 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2008 | 216 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2013 | 657 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2009 | 264 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1619 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2006 | 183 | 0.020 |
Why?
|
| Research Design | 1 | 2004 | 729 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 20881 | 0.010 |
Why?
|
| Cues | 1 | 2001 | 654 | 0.010 |
Why?
|